Compare FOR & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOR | PLSE |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2007 | 2016 |
| Metric | FOR | PLSE |
|---|---|---|
| Price | $30.31 | $23.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $31.75 | $22.00 |
| AVG Volume (30 Days) | 197.6K | ★ 438.0K |
| Earning Date | 01-20-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.27 | N/A |
| Revenue | ★ $1,685,000,000.00 | $86,000.00 |
| Revenue This Year | $0.52 | N/A |
| Revenue Next Year | $7.72 | $1,057.59 |
| P/E Ratio | $9.27 | ★ N/A |
| Revenue Growth | ★ 15.89 | N/A |
| 52 Week Low | $18.00 | $12.56 |
| 52 Week High | $30.74 | $26.30 |
| Indicator | FOR | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 71.28 | 68.37 |
| Support Level | $29.13 | $22.67 |
| Resistance Level | $29.87 | $26.30 |
| Average True Range (ATR) | 0.95 | 1.99 |
| MACD | 0.32 | 1.03 |
| Stochastic Oscillator | 93.22 | 74.69 |
Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. the company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.